Developer docs
API playgroundTry for free, no card

Search company profiles

Geistlich Biomaterials

Full company profile

uuid000c1y6

Namestring
Geistlich Biomaterials
Legal namestring
Geistlich Pharma North America, Inc.
Company typeenum
Private
Founded yearint
1851
Descriptiontext

Geistlich Biomaterials is the North American commercial arm of Swiss family-owned Geistlich Pharma AG, which has operated continuously since 1851 and now employs more than 800 people worldwide, with global headquarters and primary manufacturing in Wolhusen, Switzerland, and a regional headquarters (Geistlich Pharma North America, GPNA) in Princeton, NJ, established to serve the United States and Canada. The company develops and manufactures regenerative medical devices derived from processed xenograft tissue — principally Australian extremity-sourced bovine bone processed into Geistlich Bio-Oss bone substitute, and Swiss-sourced porcine collagen processed into Geistlich Bio-Gide membranes and the Mucograft/Fibro-Gide soft-tissue matrices — together with combination kits, Meisinger fixation hardware, bone harvesting instruments, RPM reinforced PTFE mesh, and Yxoss CBR patient-specific 3D-printed titanium scaffolds. A separate Geistlich Nexo-Gide dual-surface collagen membrane extends the platform into surgical and sports medicine. All tissue processing occurs at two sites in central Switzerland under ISO 9001/13485 quality management and EDQM TSE certification, with U.S.-distributed products sold under FDA clearance.

Geistlich sells primarily to dental professionals — periodontists, oral surgeons, and general dentists performing bone and soft-tissue regeneration around dental implants, periodontal defects, extraction sockets, and sinus floor elevations — and secondarily to surgical/sports medicine specialists, advanced wound-care providers, and U.S. government and military healthcare buyers. The company describes itself as the global market leader in regenerative dentistry, with cumulative use across more than 25 million patients (data on file, Geistlich Pharma AG), 2,800+ scientific publications validating its products, and a reported usage rate of one Geistlich product every 14 seconds worldwide. Customer and KOL engagement is reinforced by three co-founded foundations — the Osteology Foundation (2003), Osteo Science Foundation (2013), and ON Foundation (2018) — funding research and education in regenerative dentistry and orthoregeneration.

The commercial model is direct, geographically stratified, and account-based. GPNA runs a dedicated U.S./Canada field sales organization backed by clinical education programs, trade-show presence, webinars, and a digital eShop at geistlich.us; exclusive distribution arrangements cover HANSAmed in Canada and Buffalo Supply Inc. for U.S. government and Federal Supply Schedule contracts. Globally, Geistlich reaches customers through 15 country affiliates and roughly 60 third-party distributors across North America, Europe, Asia Pacific, and Latin America. Revenue is generated through one-time product sales to professional accounts; pricing is not publicly disclosed and is managed through the GPNA account system. The company is 100% family-owned with no external investors, led by CEO Diego Gabathuler, CFO Jürg Roth, CSO Dr. Mark Spilker, and Chairman Dr. Andreas Geistlich.

Short descriptiontext

Geistlich Biomaterials is the North American subsidiary of Swiss family-owned Geistlich Pharma AG (operating since 1851), producing bovine bone substitutes and porcine collagen membranes for dental and sports-medicine regeneration, distributed globally via 15 affiliates and roughly 60 partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersPrinceton, United States
HQ citystring
Princeton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regenerative biomaterials, bone graft substitutes, collagen membranes, xenograft dental products, soft tissue regeneration
Industry4 codes
PRIMARYHLAHAEAG
Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAAAGAH
Cartilage, Bone & Musculoskeletal Regeneration
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAHALAE
Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
SECONDARYHLAHAEAA
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Regenerative Dental Biomaterials
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Biomaterial Product Sales
TypeOne Time License
Description

Geistlich generates revenue primarily through the sale of regenerative biomaterial medical devices, including bone substitutes (Geistlich Bio-Oss, Geistlich Bio-Oss Collagen), collagen membranes (Geistlich Bio-Gide family), matrices (Mucograft, Mucograft Seal, Fibro-Gide), and the surgical/sports medicine product Geistlich Nexo-Gide. Products are sold directly through GPNA in the U.S. and through distributors in Canada and other markets.

geistlich-na.com
2Dental Professional Product Sales
TypeOne Time License
Description

Dental professionals (periodontists, oral surgeons, general dentists) purchase Geistlich products directly for use in regenerative dental procedures. GPNA manages these accounts with a dedicated sales force and customer care team (855-799-5500).

geistlich-na.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details1 tier
1No public pricing tiers — all sales are direct/account-based through GPNA
ModelOtherBilling cadencePay-as-you-go
Notes

Products are sold directly to dental practitioners through GPNA accounts. Pricing is managed through the GPNA account system. Government customers are served through Buffalo Supply Inc. on Federal Supply Schedule contracts.

geistlich-na.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 16 records shown
1Geistlich Bio-Oss
Description

Bone substitute material for bone regeneration in dental procedures

geistlich-na.com
+15 more records
Core offering1 text field

Geistlich Biomaterials develops, manufactures, and sells regenerative medical devices derived from xenogeneic (bovine bone and porcine collagen) sources for use in dental, oral-surgical, orthopedic, and wound-care applications. Its core offerings include bone substitutes (Geistlich Bio-Oss family), collagen membranes (Geistlich Bio-Gide family), soft-tissue matrices (Mucograft, Mucograft Seal, Fibro-Gide), and the dual-surface sports-medicine membrane Geistlich Nexo-Gide. These products serve as scaffolds that enable natural bone and soft-tissue regeneration in procedures such as dental implant placement, periodontal therapy, sinus floor elevation, and tendon repair.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • A Geistlich product is used every 14 seconds globally
+4 more records
Product overview1 text field

Geistlich Biomaterials is a Swiss family-owned company (founded 1851) specializing in regenerative biomaterials. The company offers a comprehensive portfolio of medical devices organized into four main categories: Bone Substitutes (including Geistlich Bio-Oss, Geistlich Bio-Oss Pen, Geistlich Bio-Oss Collagen, Geistlich vallomix, and vallos), Collagen Membranes (including Geistlich Bio-Gide, Geistlich Bio-Gide Compressed, Geistlich Bio-Gide Perio, Geistlich Bio-Gide Shape), Soft-tissue Matrices (including Mucograft, Mucograft Seal, Fibro-Gide), and Surgical Accessories (including bone harvesting instruments, fixation systems, and 3D customized titanium mesh). Additionally, Geistlich offers Geistlich Nexo-Gide for surgical and sports medicine applications. The company's anchor technologies—Geistlich Bio-Oss for bone regeneration and Geistlich Bio-Gide for tissue protection—form the foundation of their regenerative medicine portfolio. Geistlich operates globally with 15 affiliates and 60 distributors, serving dental professionals, surgical/sports medicine professionals, and wound care markets.

Product and service19 records
1Geistlich Bio-Oss
CategoryBone Substitutes
Description

Bovine-derived bone substitute material used for bone regeneration in dental and orthopedic applications; preserves the natural microstructure and composition of bone for osteoconductive regeneration.

2Geistlich Bio-Oss Pen
CategoryBone Substitutes
Description

Geistlich Bio-Oss bone substitute material delivered via a pen applicator for convenient handling during dental bone augmentation procedures.

3Geistlich Bio-Oss Collagen
CategoryBone Substitutes
Description

Bone substitute combining bovine bone mineral with collagen for easier handling and application in bone regeneration procedures.

4Geistlich vallomix
CategoryBone Substitutes
Description

Bone substitute material for dental bone regeneration applications.

5vallos
CategoryBone Substitutes
Description

Bone substitute material for dental regeneration procedures.

6Geistlich Bio-Gide
CategoryCollagen Membranes
Description

Porcine collagen membrane used for guided tissue and bone regeneration; features a dual-surface design with a smooth upper surface and porous lower layer to support wound healing and tissue integration.

7Geistlich Bio-Gide Compressed
CategoryCollagen Membranes
Description

Compressed version of the Geistlich Bio-Gide collagen membrane offering enhanced handling characteristics for specific surgical applications.

8Geistlich Bio-Gide Perio
CategoryCollagen Membranes
Description

Collagen membrane variant specifically designed for periodontal applications in dental regeneration.

9Geistlich Bio-Gide Shape
CategoryCollagen Membranes
Description

Pre-shaped collagen membrane variant designed for specific anatomical applications in dental procedures.

10Geistlich Mucograft
CategorySoft-Tissue Matrices
Description

Porcine collagen matrix designed for soft-tissue regeneration, used in procedures such as root coverage, alveolar ridge preservation, and recession coverage as an alternative to palate tissue grafts.

11Geistlich Mucograft Seal
CategorySoft-Tissue Matrices
Description

Collagen matrix designed for soft-tissue sealing applications, particularly for socket preservation after tooth extraction.

12Geistlich Fibro-Gide
CategorySoft-Tissue Matrices
Description

Porcine collagen matrix designed for soft-tissue augmentation and volume enhancement in dental applications.

13Geistlich Nexo-Gide
CategorySurgical & Sports Medicine Membranes
Description

FDA-cleared, resorbable, dual-surface porcine collagen bilayer membrane with a smooth upper surface and porous lower surface, used for management and protection of tendon injuries in surgical and sports medicine applications.

14Geistlich Combi-Kit
CategoryCombination Kits
Description

Combination kit pairing Geistlich Bio-Oss bone substitute with a Geistlich Bio-Gide collagen membrane for guided bone regeneration procedures.

15Geistlich Perio-System Combi-Pack
CategoryCombination Kits
Description

Combined bone substitute and membrane system packaged for periodontal regeneration procedures.

16Yxoss CBR
CategoryCustom Implants
Description

3D customized titanium mesh scaffold designed for patient-specific bone regeneration in dental applications.

17Bone Harvesting Instruments
CategorySurgical Accessories
Description

Surgical instruments designed for harvesting autogenous bone during oral surgical procedures.

18Meisinger Screws and Screw Fixation System TX
CategorySurgical Accessories
Description

Surgical screws and fixation system for membrane and bone block stabilization in regenerative dental procedures.

19Meisinger Pins and Master-Pin-Control System
CategorySurgical Accessories
Description

Pin fixation system for membrane stabilization and tissue management in oral surgery.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

HANSAmed Limited is the exclusive Canadian distributor of Geistlich Biomaterials. Based in Canada, HANSAmed serves the dental professional community in Canada, focusing on pain management, bone regeneration, periodontics, and compliance. The partnership enables Geistlich to serve the Canadian market through a specialized distributor.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Buffalo Supply Inc. serves the U.S. government and military through partnership with Geistlich Pharma North America. The company optimizes procurement and ensures compliance for a wide range of government customers, handling Federal Supply Schedule (FSS) contracts and streamlining government business for Geistlich products.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Founded in 2003 by Dr. Peter Geistlich and Geistlich Pharma AG, the Osteology Foundation promotes teaching and research and brings science and practice closer together in the field of bone and soft-tissue regeneration. Geistlich co-founded and actively supports this foundation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Launched in 2013 by Dr. Peter Geistlich and Geistlich Pharma, the Osteo Science Foundation is based in the U.S. and aims to support independent basic and applied research and enable new therapeutic approaches and clinical treatment methods in regenerative dentistry.

5ON Foundation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Founded in 2018 by Dr. Andreas Geistlich and Geistlich Pharma in the field of orthoregeneration, the ON Foundation connects young professionals, experts, and orthopedic professional associations worldwide to advance the field of orthoregeneration.

geistlich-na.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Peter Geistlich worked closely with Prof. Dr. Philip J. Boyne from Loma Linda University in California, whose pioneering work in bone regeneration led to the development of Geistlich Bio-Oss. This collaboration laid the foundation for the field of regenerative dentistry.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Regenerative medicine company focused on advanced wound care (Apligraf, Dermagraft) and surgical biologics. Comparable to Geistlich's Derma-Gide wound care line and Bio-Gide collagen membrane platform; both operate in regenerative tissue markets though Organogenesis is wound-care-led.

TypeEmerging player
Description

Regenerative medicine company producing amniotic tissue allografts (EpiFix, AmnioFix) for wound care, surgical, and dental applications. Adjacent peer competing in regenerative dental soft-tissue and bone graft markets with an alternative (human-derived) tissue platform versus Geistlich's xenograft.

3Collagen Solutions
TypeEmerging player
Description

U.K.-based developer and manufacturer of medical-grade collagen and tissue components for regenerative medicine and dental applications. Direct process-level comparable to Geistlich Bio-Gide's collagen membrane manufacturing, supplying similar dental and surgical markets at a smaller scale.

4Botiss Biomaterials
TypeDirect peer
Description

Germany-based dental regeneration specialist offering bone graft substitutes (cerabone, maxresorb), collagen membranes (collprotect, Jason), and soft-tissue matrices. Closely comparable European peer to Geistlich with overlapping product categories and customer base in periodontics and implantology.

TypeDirect peer
Description

Global leader in dental implants and a broad regenerative dentistry portfolio (including bone graft substitutes and membranes). Straumann is Geistlich's most directly comparable peer — same customer base (periodontists, oral surgeons, implantologists), same sales motion, and overlapping product categories, though Straumann is implant-led while Geistlich is biomaterials-led.

TypeDirect peer
Description

U.S. pure-play dental bone graft substitute and membrane manufacturer (RegenerOss, Biotex) spun out of Zimmer Biomet. Directly competes with Geistlich Bio-Oss and Bio-Gide in the North American regenerative dental market with similar products and customer profile.

7Dentsply Sirona
TypeBroad incumbent
Description

Largest diversified dental equipment and supplies manufacturer globally, serving the same dental professional customers as Geistlich. While Dentsply's portfolio spans implants, prosthetics, and instruments, it competes in regenerative dental materials through its MIS Implants subsidiary and distribution channels.

TypeDirect peer
Description

Specialty surgical and regenerative medicine company with meaningful dental regeneration (DynaMatrix, OraPharma) and wound care exposure. Competes with Geistlich Bio-Gide and Mucograft in dental soft-tissue regeneration and with Derma-Gide's former indications in advanced wound care.

9RTI Surgical
TypeDirect peer
Description

Tissue-based surgical implants manufacturer specializing in allograft bone grafts, sports medicine soft-tissue products, and dental regenerative materials. Competes with Geistlich Bio-Oss in bone grafting and with Geistlich's broader regenerative portfolio through surgical and dental channels.

TypeDirect peer
Description

Non-profit tissue bank producing allograft bone grafts, dermal matrices, and sports medicine tissues. Directly comparable to Geistlich's xenograft-based bone substitute and collagen membrane portfolio, with similar clinical applications in dental and orthopedic regeneration.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Geistlich Biomaterials

Regenerative Dental Biomaterialsgeistlich-na.com

Geistlich Biomaterials is the North American subsidiary of Swiss family-owned Geistlich Pharma AG (operating since 1851), producing bovine bone substitutes and porcine collagen membranes for dental and sports-medicine regeneration, distributed globally via 15 affiliates and roughly 60 partners.

What Geistlich Biomaterials does

Geistlich Biomaterials is the North American commercial arm of Swiss family-owned Geistlich Pharma AG, which has operated continuously since 1851 and now employs more than 800 people worldwide, with global headquarters and primary manufacturing in Wolhusen, Switzerland, and a regional headquarters (Geistlich Pharma North America, GPNA) in Princeton, NJ, established to serve the United States and Canada. The company develops and manufactures regenerative medical devices derived from processed xenograft tissue — principally Australian extremity-sourced bovine bone processed into Geistlich Bio-Oss bone substitute, and Swiss-sourced porcine collagen processed into Geistlich Bio-Gide membranes and the Mucograft/Fibro-Gide soft-tissue matrices — together with combination kits, Meisinger fixation hardware, bone harvesting instruments, RPM reinforced PTFE mesh, and Yxoss CBR patient-specific 3D-printed titanium scaffolds. A separate Geistlich Nexo-Gide dual-surface collagen membrane extends the platform into surgical and sports medicine. All tissue processing occurs at two sites in central Switzerland under ISO 9001/13485 quality management and EDQM TSE certification, with U.S.-distributed products sold under FDA clearance.

Geistlich sells primarily to dental professionals — periodontists, oral surgeons, and general dentists performing bone and soft-tissue regeneration around dental implants, periodontal defects, extraction sockets, and sinus floor elevations — and secondarily to surgical/sports medicine specialists, advanced wound-care providers, and U.S. government and military healthcare buyers. The company describes itself as the global market leader in regenerative dentistry, with cumulative use across more than 25 million patients (data on file, Geistlich Pharma AG), 2,800+ scientific publications validating its products, and a reported usage rate of one Geistlich product every 14 seconds worldwide. Customer and KOL engagement is reinforced by three co-founded foundations — the Osteology Foundation (2003), Osteo Science Foundation (2013), and ON Foundation (2018) — funding research and education in regenerative dentistry and orthoregeneration.

The commercial model is direct, geographically stratified, and account-based. GPNA runs a dedicated U.S./Canada field sales organization backed by clinical education programs, trade-show presence, webinars, and a digital eShop at geistlich.us; exclusive distribution arrangements cover HANSAmed in Canada and Buffalo Supply Inc. for U.S. government and Federal Supply Schedule contracts. Globally, Geistlich reaches customers through 15 country affiliates and roughly 60 third-party distributors across North America, Europe, Asia Pacific, and Latin America. Revenue is generated through one-time product sales to professional accounts; pricing is not publicly disclosed and is managed through the GPNA account system. The company is 100% family-owned with no external investors, led by CEO Diego Gabathuler, CFO Jürg Roth, CSO Dr. Mark Spilker, and Chairman Dr. Andreas Geistlich.

Geistlich Biomaterials firmographics

Firmographics
Name
Geistlich Biomaterials
Legal name
Geistlich Pharma North America, Inc.
Website
https://geistlich-na.com
Company type
Private
Founded year
1851
Operating status
Operating
Headcount range
101–250 employees
Short description
Geistlich Biomaterials is the North American subsidiary of Swiss family-owned Geistlich Pharma AG (operating since 1851), producing bovine bone substitutes and porcine collagen membranes for dental and sports-medicine regeneration, distributed globally via 15 affiliates and roughly 60 partners.
Ownership category
akta.pro rank

Geistlich Biomaterials industry classification

Industry
Product category
Regenerative Dental Biomaterials
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAEAG
Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAAAGAH
Cartilage, Bone & Musculoskeletal Regeneration
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAHALAE
Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
SECONDARYHLAHAEAA
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Regenerative biomaterials
  • Bone graft substitutes
  • Collagen membranes
  • Xenograft dental products
  • Soft tissue regeneration

Where Geistlich Biomaterials is headquartered

Location

Headquarters

HQ city
Princeton
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Geistlich Biomaterials business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Biomaterial Product Sales: Geistlich generates revenue primarily through the sale of regenerative biomaterial medical devices, including bone substitutes (Geistlich Bio-Oss, Geistlich Bio-Oss Collagen), collagen membranes (Geistlich Bio-Gide family), matrices (Mucograft, Mucograft Seal, Fibro-Gide), and the surgical/sports medicine product Geistlich Nexo-Gide. Products are sold directly through GPNA in the U.S. and through distributors in Canada and other markets.
  2. Dental Professional Product Sales: Dental professionals (periodontists, oral surgeons, general dentists) purchase Geistlich products directly for use in regenerative dental procedures. GPNA manages these accounts with a dedicated sales force and customer care team (855-799-5500).

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goNo public pricing tiers — all sales are direct/account-based through GPNA

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Geistlich Biomaterials product offering

Product offering

Core offering

Geistlich Biomaterials develops, manufactures, and sells regenerative medical devices derived from xenogeneic (bovine bone and porcine collagen) sources for use in dental, oral-surgical, orthopedic, and wound-care applications. Its core offerings include bone substitutes (Geistlich Bio-Oss family), collagen membranes (Geistlich Bio-Gide family), soft-tissue matrices (Mucograft, Mucograft Seal, Fibro-Gide), and the dual-surface sports-medicine membrane Geistlich Nexo-Gide. These products serve as scaffolds that enable natural bone and soft-tissue regeneration in procedures such as dental implant placement, periodontal therapy, sinus floor elevation, and tendon repair.

Product overview

Geistlich Biomaterials is a Swiss family-owned company (founded 1851) specializing in regenerative biomaterials. The company offers a comprehensive portfolio of medical devices organized into four main categories: Bone Substitutes (including Geistlich Bio-Oss, Geistlich Bio-Oss Pen, Geistlich Bio-Oss Collagen, Geistlich vallomix, and vallos), Collagen Membranes (including Geistlich Bio-Gide, Geistlich Bio-Gide Compressed, Geistlich Bio-Gide Perio, Geistlich Bio-Gide Shape), Soft-tissue Matrices (including Mucograft, Mucograft Seal, Fibro-Gide), and Surgical Accessories (including bone harvesting instruments, fixation systems, and 3D customized titanium mesh). Additionally, Geistlich offers Geistlich Nexo-Gide for surgical and sports medicine applications. The company's anchor technologies—Geistlich Bio-Oss for bone regeneration and Geistlich Bio-Gide for tissue protection—form the foundation of their regenerative medicine portfolio. Geistlich operates globally with 15 affiliates and 60 distributors, serving dental professionals, surgical/sports medicine professionals, and wound care markets.

Differentiator

Problem solved

Functional benefit

Brands

  • Geistlich Bio-Oss: Bone substitute material for bone regeneration in dental procedures
  • Geistlich Bio-Oss Pen
  • Geistlich Bio-Oss Collagen
  • Geistlich Bio-Gide
  • Geistlich Bio-Gide Compressed
  • Geistlich Bio-Gide Perio
  • Geistlich Bio-Gide Shape
  • Geistlich Mucograft
  • Geistlich Mucograft Seal
  • Geistlich Fibro-Gide
  • Geistlich Nexo-Gide
  • Geistlich vallomix
  • vallos
  • Geistlich Combi-Kit
  • Geistlich Perio-System Combi-Pack
  • Geistlich Orthoss

Products and services

  • Geistlich Bio-Oss Bovine-derived bone substitute material used for bone regeneration in dental and orthopedic applications; preserves the natural microstructure and composition of bone for osteoconductive regeneration.
  • Geistlich Bio-Oss Pen Geistlich Bio-Oss bone substitute material delivered via a pen applicator for convenient handling during dental bone augmentation procedures.
  • Geistlich Bio-Oss Collagen Bone substitute combining bovine bone mineral with collagen for easier handling and application in bone regeneration procedures.
  • Geistlich vallomix Bone substitute material for dental bone regeneration applications.
  • vallos Bone substitute material for dental regeneration procedures.
  • Geistlich Bio-Gide Porcine collagen membrane used for guided tissue and bone regeneration; features a dual-surface design with a smooth upper surface and porous lower layer to support wound healing and tissue integration.
  • Geistlich Bio-Gide Compressed Compressed version of the Geistlich Bio-Gide collagen membrane offering enhanced handling characteristics for specific surgical applications.
  • Geistlich Bio-Gide Perio Collagen membrane variant specifically designed for periodontal applications in dental regeneration.
  • Geistlich Bio-Gide Shape Pre-shaped collagen membrane variant designed for specific anatomical applications in dental procedures.
  • Geistlich Mucograft Porcine collagen matrix designed for soft-tissue regeneration, used in procedures such as root coverage, alveolar ridge preservation, and recession coverage as an alternative to palate tissue grafts.
  • Geistlich Mucograft Seal Collagen matrix designed for soft-tissue sealing applications, particularly for socket preservation after tooth extraction.
  • Geistlich Fibro-Gide Porcine collagen matrix designed for soft-tissue augmentation and volume enhancement in dental applications.
  • Geistlich Nexo-Gide FDA-cleared, resorbable, dual-surface porcine collagen bilayer membrane with a smooth upper surface and porous lower surface, used for management and protection of tendon injuries in surgical and sports medicine applications.
  • Geistlich Combi-Kit Combination kit pairing Geistlich Bio-Oss bone substitute with a Geistlich Bio-Gide collagen membrane for guided bone regeneration procedures.
  • Geistlich Perio-System Combi-Pack Combined bone substitute and membrane system packaged for periodontal regeneration procedures.
  • Yxoss CBR 3D customized titanium mesh scaffold designed for patient-specific bone regeneration in dental applications.
  • Bone Harvesting Instruments Surgical instruments designed for harvesting autogenous bone during oral surgical procedures.
  • Meisinger Screws and Screw Fixation System TX Surgical screws and fixation system for membrane and bone block stabilization in regenerative dental procedures.
  • Meisinger Pins and Master-Pin-Control System Pin fixation system for membrane stabilization and tissue management in oral surgery.

Quantifiable outcome

  • A Geistlich product is used every 14 seconds globally
  • +4 more outcomes

Companies that use Geistlich Biomaterials

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Geistlich Biomaterials technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Geistlich Biomaterials partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core.

  • HANSAmed LimitedcoreChannel Partner/ Reseller/ DistributorHANSAmed Limited is the exclusive Canadian distributor of Geistlich Biomaterials. Based in Canada, HANSAmed serves the dental professional community in Canada, focusing on pain management, bone regeneration, periodontics, and compliance. The partnership enables Geistlich to serve the Canadian market through a specialized distributor.
  • Buffalo Supply Inc.coreChannel Partner/ Reseller/ DistributorBuffalo Supply Inc. serves the U.S. government and military through partnership with Geistlich Pharma North America. The company optimizes procurement and ensures compliance for a wide range of government customers, handling Federal Supply Schedule (FSS) contracts and streamlining government business for Geistlich products.
  • Osteology FoundationcoreStrategic or Co-development PartnerFounded in 2003 by Dr. Peter Geistlich and Geistlich Pharma AG, the Osteology Foundation promotes teaching and research and brings science and practice closer together in the field of bone and soft-tissue regeneration. Geistlich co-founded and actively supports this foundation.
  • Osteo Science FoundationcoreStrategic or Co-development PartnerLaunched in 2013 by Dr. Peter Geistlich and Geistlich Pharma, the Osteo Science Foundation is based in the U.S. and aims to support independent basic and applied research and enable new therapeutic approaches and clinical treatment methods in regenerative dentistry.
  • ON FoundationcoreStrategic or Co-development PartnerFounded in 2018 by Dr. Andreas Geistlich and Geistlich Pharma in the field of orthoregeneration, the ON Foundation connects young professionals, experts, and orthopedic professional associations worldwide to advance the field of orthoregeneration.
  • Loma Linda University / Prof. Dr. Philip J. BoynecoreStrategic or Co-development PartnerDr. Peter Geistlich worked closely with Prof. Dr. Philip J. Boyne from Loma Linda University in California, whose pioneering work in bone regeneration led to the development of Geistlich Bio-Oss. This collaboration laid the foundation for the field of regenerative dentistry.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Geistlich Biomaterials competitors and assessment

Company assessment

Emerging players

  • Organogenesis Holdings: Regenerative medicine company focused on advanced wound care (Apligraf, Dermagraft) and surgical biologics. Comparable to Geistlich's Derma-Gide wound care line and Bio-Gide collagen membrane platform; both operate in regenerative tissue markets though Organogenesis is wound-care-led.
  • MiMedx Group: Regenerative medicine company producing amniotic tissue allografts (EpiFix, AmnioFix) for wound care, surgical, and dental applications. Adjacent peer competing in regenerative dental soft-tissue and bone graft markets with an alternative (human-derived) tissue platform versus Geistlich's xenograft.
  • Collagen Solutions: U.K.-based developer and manufacturer of medical-grade collagen and tissue components for regenerative medicine and dental applications. Direct process-level comparable to Geistlich Bio-Gide's collagen membrane manufacturing, supplying similar dental and surgical markets at a smaller scale.

Direct peers

  • Botiss Biomaterials: Germany-based dental regeneration specialist offering bone graft substitutes (cerabone, maxresorb), collagen membranes (collprotect, Jason), and soft-tissue matrices. Closely comparable European peer to Geistlich with overlapping product categories and customer base in periodontics and implantology.
  • Straumann Group: Global leader in dental implants and a broad regenerative dentistry portfolio (including bone graft substitutes and membranes). Straumann is Geistlich's most directly comparable peer — same customer base (periodontists, oral surgeons, implantologists), same sales motion, and overlapping product categories, though Straumann is implant-led while Geistlich is biomaterials-led.
  • ZimVie: U.S. pure-play dental bone graft substitute and membrane manufacturer (RegenerOss, Biotex) spun out of Zimmer Biomet. Directly competes with Geistlich Bio-Oss and Bio-Gide in the North American regenerative dental market with similar products and customer profile.
  • Integra LifeSciences: Specialty surgical and regenerative medicine company with meaningful dental regeneration (DynaMatrix, OraPharma) and wound care exposure. Competes with Geistlich Bio-Gide and Mucograft in dental soft-tissue regeneration and with Derma-Gide's former indications in advanced wound care.
  • RTI Surgical: Tissue-based surgical implants manufacturer specializing in allograft bone grafts, sports medicine soft-tissue products, and dental regenerative materials. Competes with Geistlich Bio-Oss in bone grafting and with Geistlich's broader regenerative portfolio through surgical and dental channels.
  • LifeNet Health: Non-profit tissue bank producing allograft bone grafts, dermal matrices, and sports medicine tissues. Directly comparable to Geistlich's xenograft-based bone substitute and collagen membrane portfolio, with similar clinical applications in dental and orthopedic regeneration.

Broad incumbents

  • Dentsply Sirona: Largest diversified dental equipment and supplies manufacturer globally, serving the same dental professional customers as Geistlich. While Dentsply's portfolio spans implants, prosthetics, and instruments, it competes in regenerative dental materials through its MIS Implants subsidiary and distribution channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Geistlich Biomaterials social profiles

Digital presence

Geistlich Biomaterials compliance and trust

Trust signal

Compliance3 records

Geistlich Biomaterials financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Geistlich Biomaterials leadership team

Management profile

Number of profiles

Profiles4 records

Geistlich Biomaterials subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Geistlich Biomaterials funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Geistlich Biomaterials M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Geistlich Biomaterials

What does Geistlich Biomaterials do?

Geistlich Biomaterials develops, manufactures, and sells regenerative medical devices derived from xenogeneic (bovine bone and porcine collagen) sources for use in dental, oral-surgical, orthopedic, and wound-care applications. Its core offerings include bone substitutes (Geistlich Bio-Oss family), collagen membranes (Geistlich Bio-Gide family), soft-tissue matrices (Mucograft, Mucograft Seal, Fibro-Gide), and the dual-surface sports-medicine membrane Geistlich Nexo-Gide. These products serve as scaffolds that enable natural bone and soft-tissue regeneration in procedures such as dental implant placement, periodontal therapy, sinus floor elevation, and tendon repair.

Is Geistlich Biomaterials a public or private company?

Geistlich Biomaterials is a private company. It is classified as family owned and is currently operating.

When was Geistlich Biomaterials founded?

Geistlich Biomaterials was founded in 1851. It employs 101 to 250 people.

Where is Geistlich Biomaterials based?

Geistlich Biomaterials is headquartered in Princeton, United States, in the North America region.

How does Geistlich Biomaterials make money?

Two revenue lines are on record. Biomaterial Product Sales are the primary driver. The others are dental Professional Product Sales.

Who are Geistlich Biomaterials's main competitors?

Emerging players on record are Organogenesis Holdings, MiMedx Group and Collagen Solutions. Direct peers are Botiss Biomaterials, Straumann Group, ZimVie, Integra LifeSciences, RTI Surgical and LifeNet Health. Dentsply Sirona is listed as a broad incumbent.

Does Geistlich Biomaterials have an API?

No public API is recorded for Geistlich Biomaterials.

What industry is Geistlich Biomaterials in?

Geistlich Biomaterials's product category is Regenerative Dental Biomaterials. Its primary akta.pro industry code is HLAHAEAG, Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM), with a secondary code of HLAAAGAH, Cartilage, Bone & Musculoskeletal Regeneration. Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals